Company news

INVO Fertility, Inc. news in 2026

INVO Fertility, Inc.'s news releases, calls and decks from 2026, newest first.

View company

INVO Fertility Reports Third Quarter 2026 Results Highlighting 28% Clinic Revenue Growth and Continued Positive Clinic-Level Adjusted EBITDA

November 16, 2026

INVO Fertility Partners with PatientFi to Help Make Fertility Treatment More Affordable

November 5, 2026

INVO Fertility Announces a 1: 4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026

October 27, 2026

INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference

September 25, 2026

INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

August 28, 2026

INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International

August 20, 2026

INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability

August 17, 2026

INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure

June 22, 2026

INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q

June 2, 2026

INVO Fertility Announces Fiscal Year 2025 Financial Results

June 1, 2026

INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K

April 29, 2026

INVO Fertility Announces a 1: 5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026

March 24, 2026

INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic

March 4, 2026

INVO Fertility’s Wisconsin Clinic Joins Progyny Network

March 2, 2026

INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”

February 19, 2026

INVO Fertility Announces Patent Issuance for Modified INVOcell® Device

February 11, 2026

INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth

February 4, 2026

INVO Fertility Enters into $7.5 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules

January 29, 2026

INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

January 13, 2026

Calls in 2026

Decks in 2026